Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.

Leukemia · 2020 · PMC7685975 · PMID 32231256

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Intermediate-risk patients receiving alloSCT in CR1 showed a nonsignificant trend towards improved OS, while in the favorable-risk group, OS was similar for patients receiving alloSCT or chemotherapy only.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.